INZY - Inozyme Pharma Inc
4
0.010 0.250%
Share volume: 1,459,443
Last Updated: 06-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.01
0.00%
Summary score
34%
Profitability
35%
Dept financing
30%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-20.03%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
46.82%
Debt ratio change over timeo
0%
Current Ratio
7.47%
Quick Ratio
0%
Cash Position Ratio
1.04%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-21.59%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
50.31%
Debt ratio change over timeo
0%
Current Ratio
5.82%
Quick Ratio
0%
Cash Position Ratio
0.89%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-29.16%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
66.59%
Debt ratio change over time
0%
Current Ratio
2.19%
Quick Ratio
0%
Cash Position Ratio
0.6%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INZY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 18.48% |
| Return on assets | -20.03% | 4.23% | 3.2% | 2.05% |
| Return on sales | 0% | 27.89% | 25.03% | 26.18% |
| Return on invested capital | 0% | 8.36% | 9.37% | 3.03% |
| Profitability | 0% | 92% | 79% | 69% |
| Total debt ratio | 46.82% | 81.28% | 59.58% | 92.05% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 44.32% |
| Dept financing | 13% | 22% | 16% | 50% |
| Current Ratio | 5.82% | 1.23% | 1.12% | 0.72% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0.61% |
| Cash Position Ratio | 0.89% | 0.12% | 0.5% | 0.19% |
| Liquididy | 50% | 31% | 43% | 29% |
| Short-term ratios | INZY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -21.59% | 4.32% | 3.49% | 1.05% |
| Return on sales | 0% | 28.32% | 23.63% | 18.06% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 22% |
| Total debt ratio | 50.31% | 81.66% | 60.28% | 96.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 38% | 21% | 16% | 25% |
| Current Ratio | 5.82% | 1.23% | 1.12% | 0.72% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0.61% |
| Cash Position Ratio | 0.89% | 0.12% | 0.5% | 0.19% |
| Liquididy | 50% | 34% | 42% | 24% |